Stockreport

How This Novartis Mashup Could Validate A Biotech Company's Cancer Drug [Investor's Business Daily]

Mirati Therapeutics, Inc.  (MRTX) 
Last mirati therapeutics, inc. earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mirati.com/node/5806
PDF Related news 12:34 PM ET A persistent EpiPen shortage is forcing patients and pharmacists to go to great lengths to get hold of the lifesaving injectors.... Drug Pric [Read more]